Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

94 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis.
Jawhar M, Schwaab J, Schnittger S, Meggendorfer M, Pfirrmann M, Sotlar K, Horny HP, Metzgeroth G, Kluger S, Naumann N, Haferlach C, Haferlach T, Valent P, Hofmann WK, Fabarius A, Cross NC, Reiter A. Jawhar M, et al. Among authors: meggendorfer m. Leukemia. 2016 Jan;30(1):136-43. doi: 10.1038/leu.2015.284. Epub 2015 Oct 14. Leukemia. 2016. PMID: 26464169
IDH1-R132 changes vary according to NPM1 and other mutations status in AML.
Falini B, Spinelli O, Meggendorfer M, Martelli MP, Bigerna B, Ascani S, Stein H, Rambaldi A, Haferlach T. Falini B, et al. Among authors: meggendorfer m. Leukemia. 2019 Apr;33(4):1043-1047. doi: 10.1038/s41375-018-0299-2. Epub 2019 Jan 8. Leukemia. 2019. PMID: 30622284 Free PMC article. No abstract available.
94 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page